These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15861552

  • 21. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy].
    Mikhaĭlova SV, Zakharova EIu, Bukina AM, Il'ina ES, Pokrovskaia AIa, Fedoniuk ID, Bembeeva RTs, Petrukhin AS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300
    [No Abstract] [Full Text] [Related]

  • 22. Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.
    Francis JS, Markov V, Leone P.
    J Inherit Metab Dis; 2014 May; 37(3):369-81. PubMed ID: 24288037
    [Abstract] [Full Text] [Related]

  • 23. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N, Calişkan M, Calay M, Ozmen M.
    Turk J Pediatr; 1998 May; 40(4):549-57. PubMed ID: 10028864
    [Abstract] [Full Text] [Related]

  • 24. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ.
    Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
    [Abstract] [Full Text] [Related]

  • 25. Prenatal diagnosis of Canavan disease--problems and dilemmas.
    Besley GT, Elpeleg ON, Shaag A, Manning NJ, Jakobs C, Walter JH.
    J Inherit Metab Dis; 1999 May; 22(3):263-6. PubMed ID: 10384383
    [No Abstract] [Full Text] [Related]

  • 26. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V, Rassek M, Gärtner J, Kahn T, Mödder U.
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [Abstract] [Full Text] [Related]

  • 27. Aspartoacylase supports oxidative energy metabolism during myelination.
    Francis JS, Strande L, Markov V, Leone P.
    J Cereb Blood Flow Metab; 2012 Sep; 32(9):1725-36. PubMed ID: 22617649
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease.
    Gessler DJ, Li D, Xu H, Su Q, Sanmiguel J, Tuncer S, Moore C, King J, Matalon R, Gao G.
    JCI Insight; 2017 Feb 09; 2(3):e90807. PubMed ID: 28194442
    [Abstract] [Full Text] [Related]

  • 33. A radiometric assay for aspartoacylase activity in human fibroblasts: application for the diagnosis of Canavan's disease.
    Barash V, Flhor D, Morag B, Boneh A, Elpeleg ON, Gilon C.
    Clin Chim Acta; 1991 Sep 30; 201(3):175-81. PubMed ID: 1756590
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation.
    Baslow MH.
    J Mol Neurosci; 2003 Sep 30; 21(3):185-90. PubMed ID: 14645985
    [Abstract] [Full Text] [Related]

  • 36. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
    Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, Popko B.
    J Neurosci; 2008 Nov 05; 28(45):11537-49. PubMed ID: 18987190
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Relationship between enzyme properties and disease progression in Canavan disease.
    Zano S, Wijayasinghe YS, Malik R, Smith J, Viola RE.
    J Inherit Metab Dis; 2013 Jan 05; 36(1):1-6. PubMed ID: 22850825
    [Abstract] [Full Text] [Related]

  • 39. Recent advances in Canavan disease.
    Matalon R, Michals-Matalon K.
    Adv Pediatr; 1999 Jan 05; 46():493-506. PubMed ID: 10645473
    [Abstract] [Full Text] [Related]

  • 40. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
    Mathew R, Arun P, Madhavarao CN, Moffett JR, Namboodiri MA.
    J Pharmacol Exp Ther; 2005 Oct 05; 315(1):297-303. PubMed ID: 16002461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.